IP Library Granted Patent US 11,254,903
Granted Patent B2
US 11,254,903 · App. 15/328,763 · Granted Feb 22, 2022

Method and system for suspension culture

Inventors: Michelle Louise Janas (Cardiff, GB); Aaron Dulgar Tulloch (Niskayuna, NY); Clive Glover (Cardiff, GB)
Assignee: CYTIVA SWEDEN AB
C12M23/14C12M23/26C12M27/16C12M29/10C12M41/32C12M41/34C12M41/36C12M41/48C12N5/0636
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,254,903
App. No.
15/328,763
Granted
Feb 22, 2022
Kind
B2
Abstract

The present invention relates to cell culture in bioreactors, such as flexible cellbag bioreactors. More closely the invention relates to a method and system for determining the cell density in a bioreactor culture and for controlling the perfusion rate of a suspension culture of cells in a bioreactor, comprising measuring the oxygen uptake of primary mononuclear cells in a non-static bioreactor.

Claims (19)

1. A method for regulating perfusion rate in a suspension culture of cells comprising primary mononuclear cells in a non-static bioreactor, comprising:

keeping the non-static bioreactor at a constant rocking rate of 1-25 rpm;

registering the dissolved oxygen concentration in the bioreactor;

determining the cell number of said primary mononuclear cells by a pre-determined correlation of the registered dissolved oxygen concentration with the cell number; and

automatically controlling the perfusion rate in response to the registered dissolved oxygen concentration,

wherein the pre-determined correlation is an inverse linear relationship, and

wherein no sampling of the contents of the bioreactor is performed to determine cell number.

2. The method according to claim 1 , wherein the dissolved oxygen concentration is measured by a sensor integrated in the bioreactor.

3. The method according to claim 1 , wherein the bioreactor is a flexible cell bag.

4. The method according to claim 1 , wherein the cells are T-cells.

5. The method according to claim 1 , wherein the rocking rate is 10-15 rpm and the bioreactor is a flexible cell bag.

6. The method according to claim 1 , wherein the rocking rate of the bioreactor is 10-15 rpm.

7. The method according to claim 2 , wherein the sensor is an optical sensor.

8. The method according to claim 1 , wherein the dissolved oxygen uptake is greater than 10%.

9. The method according to claim 1 , wherein the pre-determined correlation of the registered dissolved oxygen concentration (DO) with the cell number is defined by linear relationships:

DO=− 1.58 E -06*cell density+90.01 at 15 rpm and 6° angle; or

DO=− 2.88 E -06*cell density+89.81 at 10 rpm and 6° angle.

10. The method according to claim 1 , wherein controlling the perfusion rate in response to the registered dissolved oxygen concentration comprises adjusting pump rates without operator input.

11. The method according to claim 10 , wherein the pump rates control an amount of media perfused in in the non-static bioreactor.

Assignments (3)
CHANGE OF NAME Recorded Oct 5, 2020
From: GE HEALTHCARE BIO-SCIENCES AB
To: CYTIVA SWEDEN AB
Reel/Frame 054262/0184 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2017
From: JANAS, MICHELLE LOUISE; GLOVER, CLIVE; DULGAR-TULLOCH, AARON
To: GE HEALTHCARE BIO-SCIENCES AB
Reel/Frame 041090/0050 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 24, 2017
From: JANAS, MICHELLE LOUISE; GLOVER, CLIVE; DULGAR TULLOCH, AARON
To: GE HEALTHCARE BIO-SCIENCES AB
Reel/Frame 041066/0011 →